More Frequent Dupilumab Better for Atopic Dermatitis Control More Frequent Dupilumab Better for Atopic Dermatitis Control

Dupilumab 300 mg at weekly or biweekly intervals was more effective than less frequent dosing in moderate to severe atopic dermatitis and should be used for long-term maintenance, researchers say.Medscape Medical News

Source: Medscape Dermatology Headlines - December 31, 2019 Category: Dermatology Tags: Dermatology News Source Type: news